RT Journal Article
SR Electronic
T1 821 The combination of a trastuzumab ISAC and pertuzumab augments anti-tumor efficacy in multiple HER2+ tumor models relative to trastuzumab plus pertuzumab
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A919
OP A919
DO 10.1136/jitc-2023-SITC2023.0821
VO 11
IS Suppl 1
A1 Pearson, Cecelia I
A1 Luo, Andrew
A1 Henning, Karla A
A1 Lucas, Anthony
A1 Omstead, David
A1 McEachin, Katelynn A
A1 Ponath, Paul D
A1 Chapin, Steven J
A1 Ackerman, Shelley E
A1 Perez, Edith A
A1 Kim, Han K
A1 Alonso, Michael N
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A919.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.